Murray A Raskind Selected Research

Prazosin (Minipress)

1/2021	The Relative Effects of Prazosin on Individual PTSD Symptoms: Evidence for Pathophysiologically-Related Clustering.
1/2020	Optimizing Aggregated N-Of-1 Trial Designs for Predictive Biomarker Validation: Statistical Methods and Theoretical Findings.
2/2018	Evidence for altered brain reactivity to norepinephrine in Veterans with a history of traumatic stress.
1/2018	Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.
1/2018	Prazosin for Post-Traumatic Stress Disorder.
11/2016	Higher Pretreatment Blood Pressure Is Associated With Greater Posttraumatic Stress Disorder Symptom Reduction in Soldiers Treated With Prazosin.
10/2016	Noradrenergic dysregulation in the pathophysiology of PTSD.
5/2016	Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial.
1/2015	The Effects of Stress Exposure on Prefrontal Cortex: Translating Basic Research into Successful Treatments for Post-Traumatic Stress Disorder.
9/2013	A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Murray A Raskind Research Topics

Disease

21	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 02/2002
15	Alzheimer Disease (Alzheimer's Disease) 09/2017 - 03/2003
14	Wounds and Injuries (Trauma) 01/2021 - 02/2002
6	Cognitive Dysfunction 01/2021 - 02/2004
5	Brain Concussion (Cerebral Concussion) 01/2021 - 01/2011
3	Syndrome (Syndromes) 01/2021 - 02/2003
2	Dementia (Dementias) 01/2018 - 02/2004
2	Nervous System Diseases (Neurological Disorders) 01/2017 - 11/2008
2	Frontotemporal Dementia (Semantic Dementia) 10/2016 - 12/2014
2	TDP-43 Proteinopathies 10/2016 - 12/2014
2	Body Weight (Weight, Body) 02/2009 - 02/2007
1	Anhedonia 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Cerebellar Diseases (Cerebellar Syndrome) 10/2020
1	Hypercholesterolemia 09/2017
1	Vascular Diseases (Vascular Disease) 07/2017
1	Neuroinflammatory Diseases 01/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2016
1	Psychotic Disorders (Schizoaffective Disorder) 06/2014
1	Cerebrovascular Trauma 06/2014
1	Neurologic Manifestations (Neurological Manifestations) 03/2014
1	Post-Concussion Syndrome 01/2011
1	Panic Disorder (Panic Attack) 01/2010
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2009
1	Hypertension (High Blood Pressure) 09/2009
1	Alcoholism (Alcohol Abuse) 02/2009
1	Schizophrenia (Dementia Praecox) 02/2007
1	Weight Gain 02/2007
1	Cocaine-Related Disorders (Cocaine Addiction) 11/2006
1	Hallucinations (Hallucination) 11/2006
1	Seizures (Absence Seizure) 11/2004
1	Disease Progression 02/2004

Drug/Important Bio-Agent (IBA)

22	Prazosin (Minipress)FDA LinkGeneric 01/2021 - 02/2002
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2006
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2018 - 01/2005
3	Apolipoproteins E (ApoE)IBA 07/2017 - 07/2006
3	Proteins (Proteins, Gene)FDA Link 10/2016 - 03/2003
3	ApolipoproteinsIBA 09/2014 - 07/2006
3	Glucose (Dextrose)FDA LinkGeneric 03/2014 - 05/2009
3	Hormones (Hormone)IBA 02/2007 - 03/2003
2	Explosive Agents (Explosives)IBA 01/2021 - 01/2011
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018 - 01/2009
2	F2-Isoprostanes (F2 Isoprostanes)IBA 09/2014 - 06/2014
2	Free RadicalsIBA 09/2014 - 06/2014
2	Amyloid (Amyloid Fibrils)IBA 06/2014 - 03/2003
2	Antipsychotic Agents (Antipsychotics)IBA 06/2014 - 02/2007
2	Amyloid beta-PeptidesIBA 05/2009 - 07/2006
2	Pharmaceutical PreparationsIBA 02/2009 - 02/2002
2	Adrenergic Agents (Adrenergic Drugs)IBA 08/2008 - 09/2003
2	Adrenergic Antagonists (Antiadrenergic Agents)IBA 04/2006 - 09/2003
2	Galantamine (Galanthamine)FDA LinkGeneric 02/2004 - 09/2003
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2020
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	Simvastatin (Zocor)FDA LinkGeneric 09/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	Interleukin-7 (Interleukin 7)IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Detergents (Detergent)IBA 10/2016
1	CalcineurinIBA 10/2016
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 05/2016
1	Doxazosin (Cardura)FDA LinkGeneric 05/2016
1	Clonidine (ST 155)FDA LinkGeneric 01/2015
1	Guanfacine (Tenex)FDA LinkGeneric 01/2015
1	Phosphotransferases (Kinase)IBA 12/2014
1	Protons (Proton)IBA 03/2014
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2010
1	Peptides (Polypeptides)IBA 05/2009
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2009
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2009
1	AndrogensIBA 01/2009
1	Cosyntropin (Cortrosyn)FDA LinkGeneric 01/2009
1	Dehydroepiandrosterone (DHEA)IBA 01/2009
1	Antidepressive Agents (Antidepressants)IBA 11/2008
1	Hypnotics and Sedatives (Sedatives)IBA 03/2008
1	alpha-1 Adrenergic Receptors (alpha 1 Adrenergic Receptor)IBA 04/2007
1	MelatoninIBA 02/2007
1	Olanzapine (Zyprexa)FDA Link 02/2007
1	Goserelin (Zoladex)FDA Link 06/2005
1	Propranolol (Inderal)FDA LinkGeneric 01/2005
1	Galanin Receptors (Galanin Receptor)IBA 11/2004
1	GalaninIBA 11/2004
1	CalbindinsIBA 11/2004
1	Cholinergic Agents (Cholinergics)IBA 09/2003
1	Estrogens (Estrogen)FDA Link 03/2003

Therapy/Procedure

2	Institutionalization (Institutionalized Persons) 09/2009 - 11/2008
2	Home Nursing (Nursing, Home) 06/2005 - 01/2005
1	Precision Medicine 01/2020
1	Injections 01/2017
1	Aftercare (After-Treatment) 08/2008
1	Therapeutics 02/2007